Overview
Kathy Luo practices practicing medicine in Macao, China.
Her clinical expertise encompasses Breast Cancer, Beta-Propeller Protein-Associated Neurodegeneration, Lung Cancer, and Triple-Negative Breast Cancer.
She is actively involved in clinical research, co-authoring 61 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kathy Q. Luo
Is Kathy Q. Luo a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Kathy Q. Luo is classified as an Experienced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kathy Q. Luo participate in research or clinical trials?
Yes. Kathy Q. Luo has published 61 articles and abstracts on conditions like Breast Cancer. You can view a list of Kathy Q. Luo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Beta-Propeller Protein-Associated Neurodegeneration
- Breast CancerMs. Luo isExperienced. Learn about Breast Cancer.
- Lung CancerMs. Luo isExperienced. Learn about Lung Cancer.
- Triple-Negative Breast CancerMs. Luo isExperienced. Learn about Triple-Negative Breast Cancer.